Results 111 to 120 of about 1,059,853 (352)

The effect of upper instrumented vertebra level (T9 vs T10) on radiologic and functional outcomes in the surgical treatment of adult spinal deformity in osteoporotic patients over 60 years of age

open access: yesBrain and Spine, 2021
Sina Coskun   +10 more
doaj   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec   +6 more
wiley   +1 more source

Pulmonary functions after self sliding growth guidance for early-onset scoliosis with minimum five (5-13) years of follow-up

open access: yesBrain and Spine, 2021
Sinan Kahraman   +10 more
doaj   +1 more source

A New Entry Point and Trajectory for Iliac Bolt Fixation in Patients Undergoing Long Fusion to the Sacrum

open access: yesGlobal Spine Journal, 2015
Introduction Osteotomy of the posterior superior iliac spine for preparation of traditional iliac screw entry point exposes the cancellous bone of the inner ilium and causes loss of circumferential cortical starting point which may compromise ...
Meric Enercan   +6 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

The Case of a 19‐Year‐Old Woman Presenting With Headache and Transient Loss of Consciousness

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Yan Lin   +7 more
wiley   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Cervicothoracic-upper thoracic three-column osteotomy for treatment of proximal junctional failures following adult spinal surgery

open access: yesBrain and Spine, 2021
Recep Dincer   +11 more
doaj   +1 more source

Fungal infections of spine: Case series during the COVID times

open access: gold, 2022
Ishwara Keerthi C   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy